March 18, 2025 - 09:31

In a significant policy shift, the Trump administration has removed a long-standing clause from federal contracting regulations that explicitly prohibited segregated facilities. This change marks the end of a rule that had been in effect since the 1960s, which aimed to prevent discrimination and promote equal access in workplaces funded by federal contracts.
The decision has sparked considerable debate, with critics arguing that it undermines decades of progress toward workplace equality and could lead to a resurgence of discriminatory practices. Proponents of the change argue that it allows for greater flexibility for contractors and could foster a more competitive bidding environment.
As federal contracts often involve substantial financial resources, the implications of this policy alteration are significant. The removal of the ban raises questions about the future of workplace inclusivity and the potential for segregated facilities to re-emerge in environments that receive federal funding. As this policy unfolds, stakeholders across various sectors will be closely monitoring its impact on labor practices and civil rights.
July 22, 2026 - 08:37
Bradford A&E services downgraded by health watchdogA health watchdog has downgraded the accident and emergency services at Bradford Royal Infirmary following an inspection that uncovered significant concerns. The Care Quality Commission (CQC) found...
July 21, 2026 - 17:42
Rare disease drugmakers try to avoid Trump price cutsPharmaceutical companies that specialize in treatments for rare diseases are scrambling to shield their products from possible price cuts under a potential second Trump administration. During his...
July 21, 2026 - 06:41
The rise of Zyn-like pouches for sleep, health, focus, teethThe success of Zyn nicotine pouches has sparked a wave of copycat products that promise to deliver everything from better sleep to sharper focus, all through a small pouch tucked inside the lip....
July 20, 2026 - 19:14
FDA says it’s still investigating Taylor Farms in cyclosporiasis outbreakThe U.S. Food and Drug Administration has clarified that a false-positive lab result does not alter the `overwhelming epidemiological data` pointing to Taylor Farms as the source of a...